Pharmaceuticals News and Research

RSS

FDA issues complete response letter regarding the NDA for carisbamate

The U.S. Food and Drug Administration (FDA) issued a complete response letter regarding the New Drug Application (NDA) for carisbamate, an anti-epileptic drug in development, announced Ortho-McNeil-Janssen Pharmaceuticals, Inc.

23 Aug 2009

Daschle advising Obama, health industry on reform

The Washington Post: "Former Senate majority leader Thomas A. Daschle's visit to the Oval Office on Friday, at the invitation of President Obama, was more than just a meeting between two loyal friends and political allies. It also served as a reminder of what might have been."

23 Aug 2009

Adamas Pharmaceuticals forges agreement with U.S. Naval Health Research Center for evaluating triple combination antiviral drug

Adamas Pharmaceuticals, Inc., a privately held company, announced today that it has entered into a Cooperative Research and Development Agreement (CRADA) with the United States Naval Health Research Center for preclinical studies evaluating Adamas' triple combination antiviral drug (TCAD) therapy for influenza A, including novel influenza A/H1N1. TCAD therapy includes Adamas' investigational proprietary fixed-dose oral combination drug, to be administered adjunctively with a neuraminidase inhibitor, including Tamiflu (oseltamivir phosphate, Roche).

22 Aug 2009

Cortex Pharmaceuticals receives delisting notification from NYSE Amex

Cortex Pharmaceuticals, Inc. (NYSE Amex (COR)) reported that it has received a delisting notification from the NYSE Amex LLC indicating that it has not accepted the Company’s plan to regain compliance with the Exchange’s continued listing standards, as submitted by the Company in June.

21 Aug 2009

Lonza submits non-binding proposal to buy all of outstanding restricted voting shares of Patheon

The Special Committee of Independent Directors of Patheon Inc. (TSX:PTI) and Lonza Group AG (SIX:LONN) announced today that Lonza, one of the world's leading suppliers to the pharmaceutical, healthcare and life science industries, has submitted a non-binding proposal to acquire all of the outstanding Restricted Voting Shares of Patheon at a price of US$3.55 per Restricted Voting Share.

21 Aug 2009

DTC Perspectives announces second annual class of inductees into the DTC Hall of Fame

DTC Perspectives Inc., the leading training, publishing, and analytics company for direct-to-consumer marketing, is proud to announce its second annual class of inductees into the DTC Hall of Fame.

21 Aug 2009

Role of life sciences and health care industries in shaping national health care reforms emphasized at summit hosted by Cherokee Pharmaceuticals

...

21 Aug 2009

Sound Inpatient Physicians and Obama discuss on health care reform

Brett Kronenberger, M.D., a Chief Hospitalist of Sound Inpatient Physicians, and a group of community leaders held a private meeting with President Barack Obama prior to the Town Hall meeting on health care reform, in Belgrade, Montana last Friday.

21 Aug 2009

Plextronics finalizes $14 Million financing to fund its research, development and pilot manufacturing programs

Plextronics, Inc. announced today that it has completed a $14 million Series B-1 financing round. The round was led by Solvay North American Investments, LLC, a member of the Solvay Group, which is an international chemical and pharmaceutical group headquartered in Brussels, Belgium. Marking Solvay's second investment in three years, this $12 million investment makes Solvay the largest minority shareholder in Plextronics.

21 Aug 2009

Rxi Pharmaceuticals to recruit a new Chief Financial Officer

RXi Pharmaceuticals Corporation today announced that Stephen J. DiPalma, has resigned as Executive Vice President of Business Operations and Chief Financial Officer to pursue other opportunities, effective August 28, 2009.

21 Aug 2009

Real Americans share experiences, common need for patient-centric reform

Teva Pharmaceuticals USA, the world's leading generic pharmaceutical company, today announced the start of its "Patient First" project as part of the Year of Affordable Healthcare campaign. The initiative, available at: www.yearofaffordablehealth.com/patients, features a first-hand perspective of everyday Americans as they struggle with the enormous and sometimes insurmountable expense of paying for their prescription medicines.

21 Aug 2009

Physicians lack knowledge of off-label drug use and FDA approval status

In a recent national survey, a substantial minority of physicians erroneously believed that certain off-label uses of prescription drugs were approved by the Food and Drug Administration. This mistaken belief could encourage them to prescribe these drugs, despite the lack of scientific evidence supporting such use.

21 Aug 2009

QPharma releases iCertify 3.0 web-based learning application for life science industry

QPharma, Inc., the industry leader in regulatory and compliance solutions for the life science industry, announced today the release of its enhanced online training and certification program, iCertify 3.0.

21 Aug 2009

Medicago and Ajanta Pharma forge MoU to commercialize seasonal influenza VLP-based vaccines in India

Medicago Inc., a biotechnology company focused on developing highly effective and affordable vaccines based on proprietary manufacturing technologies and Virus-Like Particles (VLPs), today announced that it has signed a Memorandum of Understanding ("MOU") with Ajanta Pharma Limited ("Ajanta") to discuss and negotiate an agreement to commercialize Medicago's pandemic and seasonal influenza VLP-based vaccines in India and other territories.

21 Aug 2009

Newspapers examine debate over affordable drugs in developing countries

The Los Angeles Times examines how "activists in Washington, and Thailand and other developing countries are accusing the Obama administration of endangering access to affordable drugs to fight AIDS and other epidemic diseases."

21 Aug 2009

Omnicomm's TrialMaster EDC solution chosen by Impax Pharmaceuticals for study in Parkinson's disease

OmniComm Systems, Inc. (OTC Bulletin Board: OMCM), one of the fastest growing companies in the EDC marketplace, today announced that Impax Pharmaceuticals, the brand division of Impax Laboratories, Inc., Hayward, CA, has selected the TrialMaster EDC solution for conducting a Phase III study in patients with Parkinson's Disease. "While managing a global multi site clinical trial there can be significant challenges in getting trial data when you want it and in the format that you need it," said Suneel Gupta, PhD, Chief Scientific Officer for Impax. "The TrialMaster EDC solution provides us with an intuitive and easy to use export tool that simplifies the process. After considering multiple different EDC solutions, we selected OmniComm Systems based on its customer driven approach and reputation for delivering unparalleled service and support. Additionally, its support of industry standards has enabled us to meet our very tight corporate timelines for this important study."

21 Aug 2009

NY-ESO-1 recombinant proteins to be used in clinical trials for treating melanoma and ovarian cancer

The Bioproduction Facility at Cornell University has produced the first batch of NY-ESO-1 recombinant protein-a cancer vaccine-that will be used in clinical trials for patients facing either ovarian cancer or melanoma. The facility was developed as a partnership between The Ludwig Institute for Cancer Research and Cornell University.

21 Aug 2009

AMDL Diagnostics to focus on in vitro diagnostic cancer tests

AMDL Inc. (NYSE Alternext US: ADL), a US-based pharmaceutical company with major operations in China, announced the inauguration of AMDL Diagnostics Inc. (ADI), a new wholly-owned subsidiary that will focus on the research, development, manufacture and international sales of Onko-Sure(TM)-- AMDL's proprietary, regulatory approved in vitro diagnostic (IVD) cancer test.

21 Aug 2009

WHO says confirmed H1N1 deaths worldwide reach 1,800

According to the latest WHO report out Wednesday, the number of confirmed H1N1 (swine) flu deaths since its emergence in April has reached 1,799 - a jump from 1,462 deaths since the agency's last update, Agence France-Presse/the Australian reports.

20 Aug 2009

Software suite for comprehensive analysis of cardiac safety released by NewCardio

NewCardio, Inc., (OTC Bulletin Board: NWCI) a cardiac diagnostic technology provider, today announced that the Company has formally launched its lead product, QTinno(TM), a software suite that provides an automated, comprehensive analysis of cardiac safety for the pharmaceutical industry.

20 Aug 2009

Pharmaceuticals News and Research

FDA issues complete response letter regarding the NDA for carisbamate

Daschle advising Obama, health industry on reform

Adamas Pharmaceuticals forges agreement with U.S. Naval Health Research Center for evaluating triple combination antiviral drug

Cortex Pharmaceuticals receives delisting notification from NYSE Amex

Lonza submits non-binding proposal to buy all of outstanding restricted voting shares of Patheon

DTC Perspectives announces second annual class of inductees into the DTC Hall of Fame

Role of life sciences and health care industries in shaping national health care reforms emphasized at summit hosted by Cherokee Pharmaceuticals

Sound Inpatient Physicians and Obama discuss on health care reform

Plextronics finalizes $14 Million financing to fund its research, development and pilot manufacturing programs

Rxi Pharmaceuticals to recruit a new Chief Financial Officer

Real Americans share experiences, common need for patient-centric reform

Physicians lack knowledge of off-label drug use and FDA approval status

QPharma releases iCertify 3.0 web-based learning application for life science industry

Medicago and Ajanta Pharma forge MoU to commercialize seasonal influenza VLP-based vaccines in India

Newspapers examine debate over affordable drugs in developing countries

Omnicomm's TrialMaster EDC solution chosen by Impax Pharmaceuticals for study in Parkinson's disease

NY-ESO-1 recombinant proteins to be used in clinical trials for treating melanoma and ovarian cancer

AMDL Diagnostics to focus on in vitro diagnostic cancer tests

WHO says confirmed H1N1 deaths worldwide reach 1,800

Software suite for comprehensive analysis of cardiac safety released by NewCardio

Oxygen Measurement eBook - Easily Understand Dissolved Oxygen Measurement eBook

Latest eBooks

Editorial Focus eBook - Spatial and single-cell omics (1st edition)

Industry Focus eBook - Analytical Chemistry (3rd edition)

Industry Focus eBook - Microbiome (1st edition)

Industry Focus eBook - Cell biology (5th edition)

Improving healthcare sustainability through carbon data

A New Approach to Preventing Bladder Cancer Recurrence

Bringing real-time analytics to downstream bioprocess monitoring